Victor M. Moyo - 02 Oct 2023 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Mark Guerin, Attorney-in-Fact
Issuer symbol
TRAW
Transactions as of
02 Oct 2023
Net transactions value
$0
Form type
4
Filing time
27 Oct 2023, 16:41:11 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONTX Stock Option (right to purchase) Award $0 +125,000 $0.000000 125,000 02 Oct 2023 Common Stock 125,000 $0.7400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest over 4 years, 25% on the first anniversary of the grant and thereafter in 36 equal monthly installments over the next 3 years.